Skip to content

Outcome of Transforminal Epidural Injections in Patients with Lumbar Radicular Pain

Outcome of Transforminal Epidural Injections in Patients with Lumbar Radicular Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06656429
Enrollment
62
Registered
2024-10-24
Start date
2021-10-01
Completion date
2022-09-30
Last updated
2024-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Redicular Pain

Brief summary

Back pain is the most common chronic pain disorder of adult population. Lumbar radicular pain occurs due to irritation or compression of the nerve roots in the lower back. Various non-surgical methods can also be exercised that have been used to treat lumbar radicular pain since the ancient times. Despite the availability of various treatment options, achieving optimal pain relief and functional recovery remains challenging. Lumbar Transforaminal Epidural Steroid Injections (TFESI) are commonly used to manage this condition, but there is variability in patient response and limited data on the effectiveness of TFESI in different demographic and clinical subgroups.

Interventions

Transforaminal Epidural Steroid Injections

Sponsors

Muhammad Aamir Latif
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Quasi-experimental study

Eligibility

Sex/Gender
ALL
Age
45 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Both genders * Aged between 45 and 80 years * Experiencing lumbar radicular pain

Exclusion criteria

* History of spinal fracture or previous spinal surgery * Recurrent pain within 3 months of prior treatment * Ongoing steroid therapy * IKnown allergy to dexamethasone or lidocaine

Design outcomes

Primary

MeasureTime frameDescription
Pain score4-weekPatients were monitored for four weeks post-treatment, with follow-up visits scheduled at 1 week and 4 weeks. Pain scores were reassessed using visual analog scale (scores between 1 to 10). Lower scores meant lower pain whereas higher scores meant higher degree of pain

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026